A Study to Determine the Efficacy and Safety of 2 Doses of Org 34517 as Adjunctive Therapy in Subjects With Psychotic Major Depression (28130)(P05845)
PHASE2CompletedINTERVENTIONAL
Enrollment
273
Participants
Timeline
Start Date
July 31, 2004
Primary Completion Date
July 31, 2006
Study Completion Date
July 31, 2006
Conditions
DepressionDepressive DisordersPsychotic Disorders
Interventions
DRUG
Org 34517
low dose Org 34517
DRUG
Org 34517
high dose Org 34517
DRUG
Placebo
placebo
All Listed Sponsors
lead
Merck Sharp & Dohme LLC
INDUSTRY
NCT00212797 - A Study to Determine the Efficacy and Safety of 2 Doses of Org 34517 as Adjunctive Therapy in Subjects With Psychotic Major Depression (28130)(P05845) | Biotech Hunter | Biotech Hunter